added 2007 Wed Jan 31 20:59:44 by bhartzer
A blood thinning drug made by GlaxoSmithKline could get a boost Thursday as federal regulators are expected to grant approval for a new use in patients at risk of heart attack.
A blood thinning drug made by GlaxoSmithKline could get a boost Thursday as federal regulators are expected to grant approval for a new use in patients at risk of heart attack.
added 2006 Wed Aug 23 7:34:50 by JetteroHeller
Today's front-page article on MSN on the FDA warning on ADHD drug "Dexedrine" starts out as an article you THINK is criticising the drug. However, read the article, and look at the ads around it, and you'll see it's basically a sponsored ad for ADHD medication, sponsored by the very companies making billions from these drugs.
Today's front-page article on MSN on the FDA warning on ADHD drug "Dexedrine" starts out as an article you THINK is criticising the drug. However, read the article, and look at the ads around it, and you'll see it's basically a sponsored ad for ADHD medication, sponsored by the very companies making billions from these drugs.
